Baseline, n = 84 | Risk for SvdH Progression Baseline – Yr 1 | |
RR | 95% CI | |
DAS | 0.952 | 0.673–1.346 |
MBDA | 1.039 | 1.018–1.059 |
ACPA positivity | 3.227 | 1.045–9.970 |
At 1 yr, n = 81 | Risk for SvdH Progression Yr 1–Yr 2 | |
RR | 95% CI | |
DAS | 1.450 | 0.969–2.169 |
MBDA | 1.037 | 1.009–1.065 |
ACPA positivity | 2.339 | 1.027–5.325 |
MBDA: multibiomarker disease activity; DAS: Disease Activity Score; ACPA: anticitrullinated protein antibodies; SvdH: Sharp van der Heijde score; RR: relative risk.